Form 4 for PRAX Praxis Precision Medicines, Inc.

Accepted 2025-01-14 00:00:00 ET · period of report 2025-01-10 · accession 0001689548-25-000013 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-01-14	2025-01-12	PRAX	Nemiroff Alex	GC, Sec	F - Tax	$63.15	-579	20.9K	-3%	-$36.6K
D	2025-01-14	2025-01-10	PRAX	Nemiroff Alex	GC, Sec	A - Grant	$0.00	+11.2K	21.5K	+110%	$0
D	2025-01-14	2025-01-10	PRAX	Nemiroff Alex	GC, Sec	A - Grant	$0.00	+22.5K	22.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-01-12	F	D	579	$63.15	20,882.67	D	—	—
2	Common	Common Stock	2025-01-10	A	A	11,250	$0.00	21,461.67	D	—	—	(F1) Mr. Nemiroff was awarded 11,250 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 10, 2025. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
3	Derivative	Stock Option (Right to Buy)	2025-01-10	A	A	22,500	$0.00	22,500	D	$63.15 · — to 2035-01-10	22,500 Common Stock	(F3) The shares underlying this stock option vest over a four-year period, with 25% vesting on January 10, 2026 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.